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Lichen sclerosus (LS) is a chronic dermatosis characterized by atrophic white papules or plaques, most
commonly occurring on the anogenital skin. Blisters have been rarely described developing in the
background of extragenital LS. A 74-year-old woman with a 4-year history of sclerotic patches on the
trunk showed a ﬂaccid bulla on the lower back for 3 months. The histopathological ﬁnding of the skin
biopsy was consistent with the diagnosis of bullous LS. In this paper, we present this uncommon case,
review the literature on extragenital bullous LS, discuss the pathogenesis, and provide some treatment
options for the case.
Copyright  2013, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Lichen sclerosus (LS) is a chronic inﬂammatory disorder, with white
porcelain-like sclerotic lesions. The etiology of this chronic process
is unknown. It mainly affects the genital area in postmenopausal
women, but is rarely reported occurring exclusively on the extra-
genital area. Bullous LS is an unusual form of the disease, with
hemorrhagic bulla in the genital and/or extragenital areas.1,2 The
clinical features and long-term outcomes of patients with extra-
genital bullous LS have been poorly described. We introduce a case
with bullous LS exclusively found in the extragenital area, review
similar cases reported in the literature, and discuss the clinical
features, pathophysiology, and treatment options in an effort to
raise awareness of this rare clinical presentation.Case report
A 74-year-old woman presented with a 4-year history of asymp-
tomatic whitish patches on her abdomen and back. There was noy have no ﬁnancial or non-
tter or materials discussed in
North Road, Taipei 10449,
).
iwanese Dermatological Associatioother lesion in the genital area. She came to our clinic because a
blister occurred on her back 3 months earlier and did not subside.
Hermedical and family historywas unremarkable. On examination,
some sclerotic depigmented or hypopigmented patcheswere found
on her abdomen (Figure 1A). There was a large 6  4 cm, ivory-
colored sclerotic plaque with a tense bulla present on the lower
back (Figure 1B and C). She denied either itching or rubbing the
affected areas. Laboratory ﬁndings including a complete blood
count, urinalysis, and liver function tests were normal. Serologic
analysis was notable for a positive antinuclear antibody with a titer
of 1:40. Serology for Borrelia was negative. A biopsy specimen
showedmarked edema in the dermal papillaewith bulla formation,
atrophic epidermis featured by ﬂattening of the rete ridges, mild
orthohyperkeratosis, and homogenization of the collagen in the
reticular dermis. Mild perivascular inﬁltration of lymphocytes was
focally seen (Figure 2). Direct immunoﬂuorescence was negative.
The patient was diagnosed with extragenital bullous LS. Treat-
ment with clobetasol dipropionate ointment 0.05% (GlaxoSmith
Kline, Barnard castle, UK) and oral prednisolone (China Chemical &
Pharmaceutical Co. Ltd., Hsinchu, Taiwan) 10 mg twice daily for 4
weeks was not effective. Then, intralesional injection with triam-
cinolone (Yung Shin Pharmaceutical Co. Ltd., Taichung, Taiwan)
10 mg/mL was performed every 2 weeks for three sessions. At the
5-month return visit, the blister resolved and an atrophic whitish
plaque remained. The plaque has remained stable for 1 year and no
other new lesions have appeared.n. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 (A) The patient initially presented with sclerotic patches on her abdomen. (B)
A tense blister developed in the lesion on her back. (C) A closer view of the blister
demonstrated an irregular conﬁguration.
Figure 2 Skin biopsy of the lesion on the woman’s back revealed hyperkeratosis, at-
rophy of the stratum malpighii, pronounced edema with bulla formation in the
papillary dermis, sclerotic dermis, and mild inﬂammatory cell inﬁltrate. (Hematoxylin
and eosin, original magniﬁcation 4.)
Table 1 List of the 14 published cases of bullous lichen sclerosus (LS) exclusively in
the extragenital area.
Case First author (year
of publication)
Age at
diagnosis
(y)
Sex Location
of lesion
Treatment
1 Gottschalk HR
(1947)3
NA NA Extensive NA
2 Di Silverio A (1975)4 NA NA Extensive ACTH
3 Tudino ME (1984)5 54 F Palms and
wrists
NA
4 Klein LE (1984)6 NA NA Pretibial Tangential
excision
5 Marren P (1992)1 82 F Generalized
and scalp
NA
6 Wakelin SH (1994)7 55 F Generalized Hydroxychloroquine
7 Boulinguez S (1997)8 59 F Buttocks NA
8 Hallel-Halevy D
(1998)9
47 M Lower back Topical
corticosteroids
9 Gomez-Calcerrada
MR (1999)10
61 F Lumbar,
abdominal
area, scalp
Antiseptics,
analgesics, topical
corticosteroids,
and oral
antihistamines
10 Madan V (2008)11 84 M Generalized
and scalp
Topical
corticosteroids
and doxycycline
11 Ballester I (2009)2 80 M Back Topical clobetasol
propionate cream
12 Kimura A (2011)12 44 M Upper back Topical clobetasol
propionate cream
13 Shiver M (2012)13 14 F Posterior
neck
Topical clobetasol
propionate cream,
followed by
pimecrolimus
cream
14 Present case (2013) 74 F Back Intralesional
injection with
triamcinolone
10 mg/mL
ACTH ¼ adrenocorticotropic hormone; F ¼ female; M ¼ male; NA ¼ not available.
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Cases of bullous LS have been uncommonly reported in English
literature, occurring in genital and/or nongenital forms. After
reviewing the cases reported in published studies, bullous LS was
found exclusively at the extragenital site in only 13 cases
(Table 1).1e13 Fourteen cases with extragenital bullous LS including
ours were investigated. Among them, seven were females, four
were males, and three were not available. The age distribution was
wide, from 14 years to 84 years, but most of the patients were
elderly (average 60 years). Five of the cases were with generalized
distribution and the rest were locally involved. The most common
site for the localized lesions was the back, followed by abdomen,
palms, wrists, buttocks, the pretibial area, and the posterior neck.The extragenital LS was asymptomatic, often not itchy2; patients
usually paid attention to the disease when blister(s) formed.
The underlying cause of LS is obscure, and many factors may be
involved, such as genetic susceptibility and a link with autoimmune
mechanisms.2,10 An infectious etiology has been suggested in
bullous LS, with some reports proposing a connection with Borrelia
infection and hepatitis C.8,14 However, we could not ﬁnd any evi-
dence of this in our patient. Furthermore, although our case had a
positive antinuclear antibody with a titer of 1:40, titers that are less
than 1:160 are usually not considered as clinically signiﬁcant or
associated with autoimmune disorders.
Another postulation regarding the bullous formation of LS is
thought to result from lymphoid edema or trauma. Marked edema
with dilated vessels and hemorrhagic areas induces blister forma-
tion. Minor trauma with mechanical stress easily causes bullae
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why our case had many sclerotic patches on the trunk, but only
showed a blister on the back, where the possibility of being rubbed
by tight clothes was high.
Interestingly, there were some published cases on bullous
morphea, which can be confused clinically with LS because both
diseases may cause bullae in the sclerodermatous plaques.15
Furthermore, patients with long-standing LS that subsequently
developed new onset of bullous pemphigoid and pemphigus vul-
garis at affected sites were reported in the literature.16 Therefore, a
skin biopsy is needed to accurately differentiate the disease.
An increased risk of squamous cell carcinoma may exist in gen-
ital LS, but no increased risk of malignant transformation has been
found in extragenital LS.2 There is no deﬁnitive treatment for LS. The
use of potent corticosteroid has proved to be an effective thera-
peutic option. However, extragenital lesions are not as responsive as
genital diseases to topical corticosteroid therapy. Topical clobetasol
propionate cream resolves the problems of blistering but has little
effect on the underlying atrophic plaque.13 Our patient had a poor
response to topical and oral corticosteroids but had better resolu-
tion of the blister after intralesional corticosteroid injection.
In conclusion, we would like to emphasize the possibility of
bullous formation in patients with chronic extragenital LS. The fair
response to local triamcinolone injection provides an alternative
choice of therapy. By acknowledging this phenomenon, the clini-
cian can provide better management to the patient.
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